Arslanbekova, S M <br/><br/>
[Relationship between warfarin dosing and activity of CYP2C9 assessed by the content of losartan and its metabolite E-3174 in the urine of patients with mechanical prosthetic heart valves].  [electronic resource] 

 -  Kardiologiia  2013 
 - 21-4 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-9040 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anticoagulants--pharmacokinetics<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Biotransformation--genetics<br/>Cardiovascular Agents--pharmacokinetics<br/>Cytochrome P-450 CYP2C9<br/>Dose-Response Relationship, Drug<br/>Drug Monitoring--methods<br/>Female<br/>Genotype<br/>Heart Valve Diseases--drug therapy<br/>Heart Valve Prosthesis Implantation--methods<br/>Humans<br/>Imidazoles--pharmacokinetics<br/>Losartan--pharmacokinetics<br/>Male<br/>Middle Aged<br/>Pharmacogenetics<br/>Polymorphism, Genetic<br/>Postoperative Period<br/>Tetrazoles--pharmacokinetics<br/>Warfarin--pharmacokinetics